Free Trial

ANI Pharmaceuticals (ANIP) Earnings Date, Estimates & Call Transcripts

$61.35
-1.63 (-2.59%)
(As of 07/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(May. 10)
$0.95 Beat By $0.16
Consensus EPS
(May. 10)
$0.79
Skip Charts & View Estimated and Actual Earnings Data

ANIP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ANIP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ANI Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.72$0.72$0.72 
Q2 20241$0.84$0.84$0.84 
Q3 20241$0.75$0.75$0.75 
Q4 20241$1.02$1.02$1.02 
FY 20244$3.33$3.33 $3.33

ANIP Earnings Date and Information

ANI Pharmaceuticals last released its earnings results on May 10th, 2024. The specialty pharmaceutical company reported $0.95 earnings per share for the quarter, topping analysts' consensus estimates of $0.79 by $0.16. The business earned $137.43 million during the quarter, compared to analysts' expectations of $125.01 million. ANI Pharmaceuticals has generated $1.60 earnings per share over the last year ($1.60 diluted earnings per share) and currently has a price-to-earnings ratio of 38.3. Earnings for ANI Pharmaceuticals are expected to grow by 25.90% in the coming year, from $3.32 to $4.18 per share. ANI Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.

ANI Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2024
(Estimated)
------- 
5/10/2024Q1 2024$0.79$0.95+$0.16$1.08$125.01 million$137.43 million
2/29/2024Q4 2023$0.58$0.78+$0.20$1.52$123.02 million$131.65 million
11/8/2023Q3 2023$0.84$1.27+$0.43$1.65$111.92 million$131.83 million      
8/9/2023Q2 2023$0.64$1.28+$0.64$1.83$99.87 million$116.50 million      
5/8/2023Q1 2023$0.16$0.97+$0.81$1.88$82.99 million$106.79 million
3/9/2023Q4 2022$0.49$0.59+$0.10$1.46$86.76 million$94.23 million
11/9/2022Q3 2022$0.40$0.46+$0.06$1.47$78.71 million$83.82 million
8/8/2022Q2 2022($0.04)($0.05)($0.01)$0.84$71.00 million$73.86 million    
5/10/2022Q1 2022($0.05)($0.27)($0.22)$0.73$65.50 million$64.48 million      
3/15/2022Q4 2021$0.69$0.38($0.31)$2.48$58.25 million$60.93 million    
10/31/2021Q3 2021$0.70$1.01+$0.31$2.03$50.30 million$52.06 million    
8/5/2021Q2 2021$0.51$0.67+$0.16$2.15$47.80 million$48.63 million      
5/6/2021Q1 2021$0.71$1.04+$0.33$1.83$48.00 million$54.52 million    
3/8/2021Q4 2020$0.94$0.80($0.14)$1.60$55.10 million$57.25 million    
11/10/2020Q3 2020$0.88$0.97+$0.09$1.58$51.60 million$52.98 million    
8/6/2020Q2 2020$0.57$0.69+$0.12$2.13$45.70 million$48.47 million  
5/7/2020Q1 2020$0.89$1.04+$0.15$2.37$49.40 million$49.77 million  
2/27/2020Q4 2019$1.18$1.08($0.10)$2.27$51.63 million$47.97 million  
11/6/2019Q3$1.43$1.23($0.20)$1.82$56.10 million$51.30 million  
8/7/2019Q2 2019$1.18$1.44+$0.26$2.03$55.20 million$54.36 million

ANI Pharmaceuticals Earnings - Frequently Asked Questions

When is ANI Pharmaceuticals's earnings date?

ANI Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on ANIP's earnings history.

What guidance has ANI Pharmaceuticals issued on next quarter's earnings?

ANI Pharmaceuticals updated its FY 2024 earnings guidance on Saturday, June, 8th. The company issued revenue guidance of $520.0 million-$542.0 million, compared to the consensus revenue estimate of $513.1 million.

Did ANI Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, ANI Pharmaceuticals (NASDAQ:ANIP) reported $0.95 earnings per share (EPS) to beat the analysts' consensus estimate of $0.79 by $0.16. Learn more on analysts' earnings estimate vs. ANIP's actual earnings.

How much revenue does ANI Pharmaceuticals generate each year?

ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded annual revenue of $486.82 million.

How much profit does ANI Pharmaceuticals generate each year?

ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded net income of $18.78 million. ANIP has generated $1.60 earnings per share over the last four quarters.

What is ANI Pharmaceuticals's price-to-earnings ratio?

ANI Pharmaceuticals (NASDAQ:ANIP) has a trailing price-to-earnings ratio of 38.34 and a forward price-to-earnings ratio of 18.48.

What is ANI Pharmaceuticals's EPS forecast for next year?

ANI Pharmaceuticals's earnings are expected to grow from $3.32 per share to $4.18 per share in the next year, which is a 25.90% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:ANIP) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners